Is stem cell therapy for autism safe? What the studies say

"Is it safe?" is usually the first question parents ask us, and it is the right one. Understanding safety is the foundation of every good plan.

This article walks through what published studies have reported and how careful screening, monitoring and laboratory quality keep children safe.

What small studies have reported

Most research on stem cell therapy for autism has been small. That matters, because small studies can tell us about common side effects but may miss rare ones.

A safety study led by Sun and Dawson, published in Stem Cells Translational Medicine in 2020, gave umbilical cord tissue cells to 12 autistic children. Its purpose was to look at safety. The researchers reported on how the children tolerated the infusions and used that information to plan further research.

A 2022 systematic review in Frontiers in Pediatrics looked across five controlled studies with 325 children. The reviewers found that side effects were mostly mild, with examples such as low fever or headache. They also noted that the studies were limited in size and that larger trials are needed.

The larger randomized trial by Dawson and colleagues, published in the Journal of Pediatrics in 2020 with 180 children, focused on whether cord blood made a difference on the main measures. It found no significant difference compared with placebo. While it was not mainly a safety study, it adds to the overall picture of how children tolerated treatment in a careful setting.

Side effects families may hear about

Based on what has been reported in studies, side effects discussed with families can include:

• low fever around the time of an infusion
• headache
• tiredness or irritability for a short time
• discomfort where a line or needle was placed

Your medical team should go through these with you before anything happens, explain what is normal, and tell you exactly who to contact if you have a worry.

Where research is heading

Research continues to grow, and studies are exploring:

• Longer follow up. Following children over more years.
• Larger groups. Bigger studies help build a fuller picture.
• Laboratory standards. How careful preparation supports consistent quality.
• Matching the right child. Learning which children may be most suitable.

Knowing where research is heading helps you make a calm, informed choice and ask good questions.

How screening and monitoring work

Safety starts long before any treatment. A careful process usually includes:

1. A full review of your child's history, including diagnoses, medicines, allergies and past reactions.
2. Health checks and tests to make sure there is no reason to pause or say no.
3. A clear plan for the day, including how your child will be supported if they find medical settings hard.
4. Close observation during and after any session.
5. Follow up over the following weeks, with an easy way to reach the medical team.

In our programme, we also track a range of measures over time, so changes can be discussed together rather than guessed at.

What a calm treatment day looks like

Many parents tell us the day itself felt gentler than they expected. Our team plans each step around your child, with quiet spaces, familiar comfort items and plenty of time. You stay close to your child throughout, and the medical team explains what is happening at each stage. Afterwards there is time to rest before you head back to your hotel, and you will know exactly how to reach us that evening and in the days that follow.

Why laboratory quality matters

When cells are prepared for use, the laboratory is where many safety decisions are made. That includes how donors are screened, how cells are processed, how they are tested for contamination and how they are stored and transported.

At MRC Healthcare, the operator of Bangkok Autism Care, cells are prepared in our own in house laboratory. The laboratory holds ISO 9001:2015 quality management certification and is GMP certified. GMP stands for Good Manufacturing Practice, a set of standards about consistent, controlled preparation and record keeping.

These certifications show that the laboratory works to recognised, audited standards, and they give you something concrete to ask about.

Questions to ask about any laboratory

• Is the laboratory owned and run by the provider, or is the work sent elsewhere?
• What certifications does it hold, and when were they last audited?
• How are cells tested before they are released?
• Can you explain the records that are kept for each preparation?

Putting it all together

Here is a summary of where things stand. In published studies, stem cell therapy for autism has mostly been reported as well tolerated, with mild side effects, and larger trials are building on that work. And careful screening, monitoring and laboratory quality are central to doing this responsibly.

If you are weighing this up, it can help to write down your own questions before speaking with anyone. Many parents find it useful to note what worries them most, what they have already tried and what they would need to know to feel comfortable. Bringing that list to a review keeps the conversation focused on your child.

You can read more about the evidence, including its limits, on our stem cell therapy for autism page.

If safety is on your mind, that is a good place to start a conversation. Our medical team is happy to go through your child's history with you, answer your questions honestly and explain whether stem cell therapy may or may not be suitable. A first review is free, and there is never any pressure. You can send us an enquiry whenever you are ready.